Sign in

CIK 0001125345

  • Non-accelerated filer
  • Smaller reporting company

MACROGENICS INC

Sign in to watch
Ticker
MGNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-251-5172
Business address
9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-02-28 Cilinski Lynn VP, Controller and Treasurer Exercise or conversion +7,989 $0.94 $8K 17,901
2018-02-28 Cilinski Lynn VP, Controller and Treasurer Exercise or conversion +7,989 $1.51 $12K 25,890
2018-02-28 Cilinski Lynn VP, Controller and Treasurer Sale −23,967 $25.01 $599K 1,923
2018-02-28 Cilinski Lynn VP, Controller and Treasurer Exercise or conversion · Employee stock option (right to buy) −7,989 0
2018-02-28 Cilinski Lynn VP, Controller and Treasurer Exercise or conversion · Employee stock option (right to buy) −7,989 0
2018-02-28 Cilinski Lynn VP, Controller and Treasurer Exercise or conversion · Employee stock option (right to buy) −7,989 0
2018-02-26 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Shares withheld for taxes −11,070 $23.46 $260K 18,930
2018-01-24 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion +3,000 $0.94 $3K 12,100
2018-01-24 Risser Eric Blasius Sr VP & Chief Business Officer Sale −3,000 $22.50 $68K 9,100
2018-01-24 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion · Employee stock option (right to buy) −3,000 26,497
2018-01-24 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion +3,000 $0.94 $3K 12,100
2018-01-24 Risser Eric Blasius Sr VP & Chief Business Officer Sale −3,000 $22.50 $68K 9,100
2018-01-24 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion · Employee stock option (right to buy) −3,000 26,497
2018-01-17 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Exercise or conversion +2,524 $4.70 $12K 32,524
2018-01-17 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Sale −2,524 $20.00 $50K 30,000
2018-01-17 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Exercise or conversion · Employee stock option (right to buy) −2,524 45,448
2018-01-17 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion +2,000 $0.94 $2K 9,100
2018-01-17 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion · Employee stock option (right to buy) −2,000 29,497
2018-01-16 Karrels James SVP, CFO and Secretary Exercise or conversion +6,516 $0.94 $6K 119,847
2018-01-16 Karrels James SVP, CFO and Secretary Exercise or conversion · Employee stock option (right to buy) −6,516 0

Page 33 of 35 · 684 trades